Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Krystal Biotech, Inc. - Common Stock (NQ:KRYS)

197.93 -2.04 (-1.02%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 249,530
Open 200.08
Bid (Size) 170.50 (100)
Ask (Size) 313.95 (200)
Prev. Close 199.97
Today's Range 192.52 - 200.08
52wk Range 122.80 - 212.98
Shares Outstanding 22,205,642
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's Driving the Market Sentiment Around Krystal Biotech Inc?
 
Via Benzinga
Krystal Biotech (KRYS) Q3 2025 Earnings Transcript
Krystal Biotech (KRYS) Q3 2025 Earnings Transcript 
Via The Motley Fool
Topics Earnings

Performance

YTD
+26.5%
+26.5%
1 Month
+8.1%
+8.1%
3 Month
+45.4%
+45.4%
6 Month
+44.3%
+44.3%
1 Year
+8.1%
+8.1%

More News

Read More
Krystal Biotech (KRYS) Q3 2025 Earnings Top Estimates on Strong VYJUVEK Sales
Via Chartmill
Earnings Scheduled For November 3, 2025
Via Benzinga
$1000 Invested In Krystal Biotech 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Expert Outlook: Krystal Biotech Through The Eyes Of 9 Analysts
Via Benzinga
Earnings Scheduled For August 4, 2025
Via Benzinga
Earnings Outlook For Krystal Biotech
Via Benzinga
Analyst Expectations For Krystal Biotech's Future
Via Benzinga
$100 Invested In Krystal Biotech 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Insider Confidence Shines: Krystal Biotech and Growth Stocks with Strong Management Stakes Navigate Volatile Markets
Via MarketMinute
Topics Artificial Intelligence World Trade
What's Driving the Market Sentiment Around Krystal Biotech Inc?
Via Benzinga
6 Stocks Goldman Sachs Says Are Poised For Potential Acquisition In Next 12 Months — Including A Huge 200% Winner
Via Benzinga
If You Invested $1000 In Krystal Biotech Stock 5 Years Ago, You Would Have This Much Today
Via Benzinga
Here's How Much $100 Invested In Krystal Biotech 5 Years Ago Would Be Worth Today
Via Benzinga
FDA Expands Krystal Biotech Vyjuvek's Label Allowing Newborns Access To Gene Therapy For Blistering Skin
Via Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
Via Benzinga
A Glimpse Into The Expert Outlook On Krystal Biotech Through 10 Analysts
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today
Via Benzinga
What 8 Analyst Ratings Have To Say About Krystal Biotech
Via Benzinga
Crude Oil Falls 1.5%; ON Semiconductor Shares Plunge After Q2 Results
Via Benzinga
Krystal (KRYS) Q2 Profit Jumps 143%
Via The Motley Fool
KRYSTAL BIOTECH INC (NASDAQ:KRYS) Q2 2025 Earnings Beat Estimates as VYJUVEK Drives Strong Revenue Growth
Via Chartmill
Topics Earnings
Here's How Much $100 Invested In Krystal Biotech 5 Years Ago Would Be Worth Today
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Via Benzinga

Frequently Asked Questions

Is Krystal Biotech, Inc. - Common Stock publicly traded?
Yes, Krystal Biotech, Inc. - Common Stock is publicly traded.
What exchange does Krystal Biotech, Inc. - Common Stock trade on?
Krystal Biotech, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Krystal Biotech, Inc. - Common Stock?
The ticker symbol for Krystal Biotech, Inc. - Common Stock is KRYS on the Nasdaq Stock Market
What is the current price of Krystal Biotech, Inc. - Common Stock?
The current price of Krystal Biotech, Inc. - Common Stock is 197.93
When was Krystal Biotech, Inc. - Common Stock last traded?
The last trade of Krystal Biotech, Inc. - Common Stock was at 11/07/25 04:00 PM ET
What is the market capitalization of Krystal Biotech, Inc. - Common Stock?
The market capitalization of Krystal Biotech, Inc. - Common Stock is 4.40B
How many shares of Krystal Biotech, Inc. - Common Stock are outstanding?
Krystal Biotech, Inc. - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.